Internal medicine is intertwined with Oncology and Endocrinology in his research. Jeffrey R. Marks integrates Oncology with Cancer research in his study. Jeffrey R. Marks conducts interdisciplinary study in the fields of Cancer research and Tumor suppressor gene through his works. Jeffrey R. Marks undertakes multidisciplinary studies into Endocrinology and Internal medicine in his work. In his study, Jeffrey R. Marks carries out multidisciplinary Gene and Phosphorylation research. He integrates Phosphorylation with Gene in his research. Jeffrey R. Marks brings together Cancer and Angiogenesis to produce work in his papers. Jeffrey R. Marks merges many fields, such as Angiogenesis and Carcinogenesis, in his writings. Jeffrey R. Marks integrates Carcinogenesis with Tumor suppressor gene in his research.
His Cancer study combines Breast cancer, Ovarian cancer and Carcinogenesis studies. In his works, he conducts interdisciplinary research on Breast cancer and Cancer research. Jeffrey R. Marks performs integrative study on Cancer research and Carcinogenesis. He merges many fields, such as Ovarian cancer and Cancer, in his writings. His Internal medicine study frequently draws connections between adjacent fields such as Serous fluid. His Genetics study frequently links to related topics such as Gene expression. Borrowing concepts from Pathology, Jeffrey R. Marks weaves in ideas under Oncology. He performs multidisciplinary studies into Pathology and Oncology in his work. He performs multidisciplinary studies into Biochemistry and Gene in his work.
In his study, In situ is inextricably linked to Meteorology, which falls within the broad field of Infiltration (HVAC). Borrowing concepts from Meteorology, he weaves in ideas under In situ. His research investigates the link between Kurtosis and topics such as Statistics that cross with problems in Confidence interval. He combines Confidence interval and Statistics in his research. He integrates many fields, such as Cancer and Pathology, in his works. He integrates Pathology and Cancer in his research. He combines Cancer research and Colorectal cancer in his research. He conducts interdisciplinary study in the fields of Colorectal cancer and Somatic evolution in cancer through his research. In his works, Jeffrey R. Marks undertakes multidisciplinary study on Somatic evolution in cancer and Cancer research.
With his scientific publications, his incorporates both Cancer research and Cancer. Jeffrey R. Marks conducts interdisciplinary study in the fields of Cancer and Magnetic resonance imaging through his research. His work blends Magnetic resonance imaging and Radiology studies together. Jeffrey R. Marks undertakes interdisciplinary study in the fields of Radiology and Oncology through his research. Jeffrey R. Marks performs integrative Oncology and Internal medicine research in his work. His Internal medicine study frequently intersects with other fields, such as Neoadjuvant therapy. His Neoadjuvant therapy study often links to related topics such as Breast cancer. Jeffrey R. Marks performs multidisciplinary study in the fields of Breast cancer and Cancer research via his papers. With his scientific publications, his incorporates both Cell biology and Biochemistry.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt;Robert S. Fulton;Michael D. McLellan;Heather Schmidt.
Oncogenic pathway signatures in human cancers as a guide to targeted therapies.
Andrea H. Bild;Guang Yao;Jeffrey T. Chang;Quanli Wang.
Predicting the clinical status of human breast cancer by using gene expression profiles.
Mike West;Carrie Blanchette;Holly Dressman;Erich Huang.
Proceedings of the National Academy of Sciences of the United States of America (2001)
BRCA1 mutations in primary breast and ovarian carcinomas
P. Andrew Futreal;Qingyun Liu;Donna Shattuck-Eidens;Charles Cochran.
Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer.
Giovanni Ciriello;Giovanni Ciriello;Michael L. Gatza;Michael L. Gatza;Andrew H. Beck;Matthew D. Wilkerson.
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.
Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf.
Pan-cancer analysis of whole genomes
Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart.
Young Age at Diagnosis Correlates With Worse Prognosis and Defines a Subset of Breast Cancers With Shared Patterns of Gene Expression
Carey K. Anders;David S. Hsu;Gloria Broadwater;Chaitanya R. Acharya.
Journal of Clinical Oncology (2008)
Genomic signatures to guide the use of chemotherapeutics.
Anil Potti;Holly K Dressman;Andrea Bild;Richard F Riedel.
Nature Medicine (2006)
Compromised HOXA5 function can limit p53 expression in human breast tumours
Venu Raman;Shelby A. Martensen;David Reisman;Ella Evron.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: